Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma
- PMID: 20133930
- PMCID: PMC2874447
- DOI: 10.1164/rccm.200905-0695OC
Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma
Abstract
Rationale: Exhaled nitric oxide (Fe(NO)) is a biomarker of airway inflammation in mild to moderate asthma. However, whether Fe(NO) levels are informative regarding airway inflammation in patients with severe asthma, who are refractory to conventional treatment, is unknown. Here, we hypothesized that classification of severe asthma based on airway inflammation as defined by Fe(NO) levels would identify a more reactive, at-risk asthma phenotype.
Methods: Fe(NO) and major features of asthma, including airway inflammation, airflow limitation, hyperinflation, hyperresponsiveness, and atopy, were determined in 446 individuals with various degrees of asthma severity (175 severe, 271 non-severe) and 49 healthy subjects enrolled in the Severe Asthma Research Program.
Measurements and main results: Fe(NO) levels were similar among patients with severe and non-severe asthma. The proportion of individuals with high Fe(NO) levels (>35 ppb) was the same (40%) among groups despite greater corticosteroid therapy in severe asthma. All patients with asthma and high Fe(NO) had more airway reactivity (maximal reversal in response to bronchodilator administration and by methacholine challenge), more evidence of allergic airway inflammation (sputum eosinophils), more evidence of atopy (positive skin tests, higher serum IgE and blood eosinophils), and more hyperinflation, but decreased awareness of their symptoms. High Fe(NO) identified those patients with severe asthma characterized by the greatest airflow obstruction and hyperinflation and most frequent use of emergency care.
Conclusions: Grouping of asthma by Fe(NO) provides an independent classification of asthma severity, and among patients with severe asthma identifies the most reactive and worrisome asthma phenotype.
Figures

Similar articles
-
The relationship between exhaled nitric oxide measured with an off-line method and airway reversible obstruction in Japanese adults with asthma.Allergol Int. 2007 Mar;56(1):37-43. doi: 10.2332/allergolint.O-06-439. Epub 2007 Jan 29. Allergol Int. 2007. PMID: 17259808
-
Exhaled nitric oxide--is it really a good marker of airway inflammation in bronchial asthma?Respiration. 2000;67(6):645-51. doi: 10.1159/000056294. Respiration. 2000. PMID: 11124647
-
Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody.Pediatrics. 2004 Apr;113(4):e308-12. doi: 10.1542/peds.113.4.e308. Pediatrics. 2004. PMID: 15060258 Clinical Trial.
-
Exhaled nitric oxide: a test for diagnosis and control of asthma?Curr Allergy Asthma Rep. 2007 Nov;7(6):459-63. doi: 10.1007/s11882-007-0070-7. Curr Allergy Asthma Rep. 2007. PMID: 17986377 Review.
-
Fractional exhaled nitric oxide in asthma: an update.Respirology. 2010 Jan;15(1):57-70. doi: 10.1111/j.1440-1843.2009.01616.x. Epub 2009 Sep 16. Respirology. 2010. PMID: 19761537 Review.
Cited by
-
Mind-body interactions in the regulation of airway inflammation in asthma: A PET study of acute and chronic stress.Brain Behav Immun. 2016 Nov;58:18-30. doi: 10.1016/j.bbi.2016.03.024. Epub 2016 Mar 30. Brain Behav Immun. 2016. PMID: 27039241 Free PMC article.
-
Control of asthma in real life: still a valuable goal?Eur Respir Rev. 2015 Jun;24(136):361-9. doi: 10.1183/16000617.00001615. Eur Respir Rev. 2015. PMID: 26028647 Free PMC article. Review.
-
Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease.J Clin Med. 2020 Aug 18;9(8):2670. doi: 10.3390/jcm9082670. J Clin Med. 2020. PMID: 32824775 Free PMC article. Review.
-
Asthma with Fixed Airflow Obstruction: From Fixed to Personalized Approach.J Pers Med. 2022 Feb 23;12(3):333. doi: 10.3390/jpm12030333. J Pers Med. 2022. PMID: 35330333 Free PMC article. Review.
-
Performance of fractional exhaled nitric oxide in predicting response to inhaled corticosteroids in chronic cough: a meta-analysis.Ann Med. 2021 Dec;53(1):1659-1672. doi: 10.1080/07853890.2021.1979242. Ann Med. 2021. PMID: 34528479 Free PMC article.
References
-
- Busse WW, Banks-Schlegel S, Wenzel SE. Pathophysiology of severe asthma. J Allergy Clin Immunol 2000;106:1033–1042. - PubMed
-
- American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2000;162:2341–2351. - PubMed
-
- Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001–1008. - PubMed
-
- National Asthma Education and Prevention Program, National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and the management of asthma: expert panel report II. Bethesda, MD: National Institutes of Health; 1997.
-
- Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360:1715–1721. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HL69174/HL/NHLBI NIH HHS/United States
- UL1 TR000005/TR/NCATS NIH HHS/United States
- M01 RR018390/RR/NCRR NIH HHS/United States
- HL69167/HL/NHLBI NIH HHS/United States
- U10HL74225/HL/NHLBI NIH HHS/United States
- HL069155/HL/NHLBI NIH HHS/United States
- UL1 TR000448/TR/NCATS NIH HHS/United States
- HL69170/HL/NHLBI NIH HHS/United States
- HL69149/HL/NHLBI NIH HHS/United States
- P01/U01 HL67663/HL/NHLBI NIH HHS/United States
- HL69116/HL/NHLBI NIH HHS/United States
- AI70649/AI/NIAID NIH HHS/United States
- HL069349/HL/NHLBI NIH HHS/United States
- HL04265/HL/NHLBI NIH HHS/United States
- HL68863/HL/NHLBI NIH HHS/United States
- HL69130/HL/NHLBI NIH HHS/United States
- P01/U01HL67663/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical